Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application
pharmaceutical investing scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX
Standard Uranium Retains 100% Unencumbered Ownership of the Sun Dog Project Through Conclusion of Property Option Agreement
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea
